Access to antiviral therapy for chronic hepatitis B during COVID-19

Marilia Rocha Bertolli1, Priscilla Alves Rocha1, Vanusa Barbosa Pinto1

  • 1Universidade de São Paulo, Faculty of Medicine, Hospital das Clínicas, Pharmacy Division - São Paulo (SP), Brazil.

Revista Da Associacao Medica Brasileira (1992)
|November 30, 2022
PubMed

Insights

During the COVID-19 pandemic, access to hepatitis B antiviral therapy was limited for women and older adults. A home medication delivery program improved access for chronic hepatitis B patients.

Area of Science:

  • Hepatology
  • Public Health
  • Infectious Diseases

Background:

  • Hepatitis B is a significant global health issue.
  • The COVID-19 pandemic has disrupted healthcare access for chronic disease management.
  • Contingency measures may have impacted hepatitis B treatment availability.

Purpose of the Study:

  • To assess access to antiviral therapy for chronic hepatitis B patients during the COVID-19 pandemic.
  • To identify patient groups with challenges in accessing hepatitis B treatment.
  • To evaluate the effectiveness of a medication delivery program.

Main Methods:

  • Descriptive analysis of treatment access for 225 chronic hepatitis B patients.
  • Study conducted at a tertiary university hospital in São Paulo, Brazil.
  • Data collected from April to December 2020.

Main Results:

  • The Home Medication Delivery Program (HMDP) served 64% of patients.
  • Women (56%) and individuals over 48 years old (70%) showed poorer access to antiviral therapy.
  • Patients in the HMDP (68%) had improved access.

Conclusions:

  • The study identified specific demographics at higher risk of limited access to hepatitis B antiviral therapy.
  • A medication delivery system demonstrated benefits in maintaining treatment access during a public health crisis.
  • Findings aid in optimizing public health strategies during pandemics.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
85
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
76
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13